SydneyX.LuMD

PubMed

• Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
  Johannes L Zakrzewski, David Suh, John C Markley, Odette M Smith, Christopher King, Gabrielle L Goldberg, Robert Jenq, Amanda M Holland, Jeremy Grubin, Javier Cabrera-...> ;Nature Biotechnology. 2024 Mar 26
• E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial.
  Jan Philipp Bewersdorf, Justin Taylor, Xiaoli Mi, Namrata Sonia Chandhok, Justin Watts, Andriy Derkach, Mateusz Wysocki, Sydney X Lu, Jessie Bourcier, Simon J Hogg, Ja...> ;Leukemia. 2023 Dec 1
• 8 citations
  Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
  Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, Justin Taylor, Eileen Boyle, Juan Arango Ossa, Jacob Jahn, Maurizio Affer, Tulasigeri M Totiger, David Coffey, ...> ;Blood. 2023 May 11
• 13 citations
  Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
  Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, Meghan Salcedo, Kelly Barnett, Julia Caple, Jenna Blaslov, Linh Tran, Amanda Ciardiello, Miranda Burge, Tala Shekarkha...> ;Clinical Cancer Research. 2022 Dec 1
• 27 citations
  Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, len...
  Katrina M Piedra, Tim J Peterson, Carlyn Tan, Jennifer S. Orozco, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Alexander M. Lesokhin, Urvi A Shah, Sydney Lu, Dhwan...> ;British Journal of Haematology. 2021 Aug 15
• 108 citations
  Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Cell. 2021 Jul 22
• 36 citations
  Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial.
  Benjamin Diamond, Neha Korde, Alexander M. Lesokhin, Eric L. Smith, Urvi A Shah, Sham Mailankody, Malin Hultcrantz, Hani Hassoun, Sydney X. Lu, Carlyn Tan, Even H Rust...> ;The Lancet. Haematology. 2021 Jun 1
• 45 citations
  Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: Th...
  Ola Landgren, Malin Hultcrantz, Benjamin Diamond, Alexander M. Lesokhin, Sham Mailankody, Hani Hassoun, Carlyn Tan, Urvi A Shah, Sydney X. Lu, Meghan Salcedo, Kelly We...> ;JAMA Oncology. 2021 Jun 1
• 51 citations
  Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.
  Daichi Inoue, Jacob T. Polaski, Justin Taylor, Pau Castel, Sisi Chen, Susumu Kobayashi, Simon J. Hogg, Yasutaka Hayashi, Jose Mario Bello Pineda, Ettaib El Marabti, Ca...> ;Nature Genetics. 2021 Apr 12
• 7 citations
  Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m 2 ) in co...
  Neha Korde, Donna Mastey, Elizabet Tavitian, Sham Mailankody, Alexander M. Lesokhin, Hani Hassoun, Eric L. Smith, Nikoletta Lendvai, Malin Hultcrantz, Urvi A Shah, Car...> ;American Journal of Hematology. 2021 Mar 19
• 6 citations
  Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy.
  Marion Eveillard, Neha Korde, Amanda Ciardiello, Benjamin Diamond, Alexander M. Lesokhin, Sham Mailankody, Eric L. Smith, Hani Hassoun, Malin Hultcrantz, Urvi A Shah, ...> ;Clinica Chimica Acta; International Journal of Clinical Chemistry. 2021 Feb 2
• Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
  Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi A Shah, Alexander M. Lesokhin, Hani H...> ;Blood Cancer Discovery. 2020 Nov 4
• 31 citations
  Accelerated single cell seeding in relapsed multiple myeloma.
  Heather Landau, Venkata Yellapantula, Benjamin Diamond, Even H Rustad, Kylee H Maclachlan, Gunes Gundem, Juan S. Medina-Martinez, Juan E. Arango Ossa, Max Levine, Yang...> ;Nature Communications. 2020 Jul 17
• 23 citations
  COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
  , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Medrxiv. 2020 Jun 11
• 34 citations
  Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with m...
  Marion Eveillard, Even H Rustad, Mikhail Roshal, Yanming Zhang, Amanda Ciardiello, Neha Korde, Malin Hultcrantz, Sydney X. Lu, Urvi A Shah, Hani Hassoun, Eric L. Smith...> ;British Journal of Haematology. 2020 Feb 5
• 6 citations
  Modern treatments and future directions for newly diagnosed multiple myeloma patients
  Sydney X. Lu> ;Best Practice & Research. Clinical Haematology. 2020 Jan 23
• 95 citations
  Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
  Benjamin H. Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, David H. Abramson, Veronica Rotemberg, Steven De Munck, Erwin Pannecoucke, Sydney X. Lu, Alessandro Pas...> ;Nature Medicine. 2019 Nov 25
• 129 citations
  Spliceosomal disruption of the non-canonical BAF complex in cancer.
  Daichi Inoue, Guo-Liang Chew, Bo Liu, Brittany C. Michel, Joseph Pangallo, Andrew R. D’Avino, Tyler D. Hitchman, Khrystyna North, Stanley Chun-Wei Lee, Lillian Bitner,...> ;Nature. 2019 Oct 9
• 51 citations
  Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
  Ola Landgren, Jonathan N. Hofmann, Charlene McShane, Loredana Santo, Malin Hultcrantz, Neha Korde, Sham Mailankody, Dickran Kazandjian, Kazunori Murata, Katie L. Thore...> ;JAMA Oncology. 2019 Sep 1
• 48 citations
  Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL.
  Alessandro Pastore, Federico Gaiti, Sydney X. Lu, Ryan M. Brand, Scott Kulm, Ronan Chaligne, Hongcang Gu, Kevin Y. Huang, Elena K. Stamenova, Wendy Béguelin, Yanwen Ji...> ;Nature Communications. 2019 Apr 23
• 180 citations
  Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
  Eric Wang, Sydney X. Lu, Alessandro Pastore, Xufeng Chen, Jochen Imig, Stanley Chun-Wei Lee, Kathryn Hockemeyer, Yohana Ghebrechristos, Akihide Yoshimi, Daichi Inoue, ...> ;Cancer Cell. 2019 Mar 18
• 132 citations
  Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.
  Stanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, Eun Jung Jang, Esther A. Obeng, Sydney X. Lu, Bo Liu, Daichi Inoue, Akihide Yoshimi, Michelle Ki, Mirae Yeo, Xiao Ji...> ;Cancer Cell. 2018 Aug 13
• 25 citations
  MRD Testing in Multiple Myeloma: The Main Future Driver for Modern Tailored Treatment.
  Ola Landgren, Sydney X. Lu, Malin Hultcrantz> ;Seminars in Hematology. 2018 Jan 1
• 68 citations
  Genomic Analysis of Hairy Cell Leukemia Identifies Novel Recurrent Genetic Alterations
  Benjamin H. Durham, Bartlomiej Getta, Sascha Dietrich, Justin Taylor, Helen Won, James M Bogenberger, Sasynia N Scott, Eunhee Kim, Young Rock Chung, Stephen S. Chung, ...> ;Blood. 2017 Oct 5
• 71 citations
  Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
  Akihide Yoshimi, Maria E. Balasis, Alexis Vedder, Kira Feldman, Yan Ma, Hailing Zhang, Stanley Chun-Wei Lee, Christopher Letson, Sandrine Niyongere, Sydney X. Lu, Mark...> ;Blood. 2017 Jul 27
• Join now to see all